The Department of Health and Human Services recently distributed 27,000 portable COVID-19 molecular test kits, which Alaska, Florida, Louisiana, New Jersey, and Texas can use at the point of care to verify antigen test results within 20 minutes. The pilot program is part of a $481 million contract with Cue Health that HHS and the Department of Defense announced last month. The Food and Drug Administration in June authorized the testing system’s emergency use in patient care settings operating under a CLIA certificate of waiver, compliance or accreditation. “The pilot program will help us determine how well the Cue test will be adapted in institutions and communities,” said HHS Assistant Secretary for Health Brett Giroir, M.D.

Related News Articles

Headline
As urged by the AHA, the Department of Health and Human Services today renewed the COVID-19 public health emergency declaration for another 90 days…
Headline
The Centers for Medicare & Medicaid Services today released updated interpretive guidance on its Omnibus COVID-19 Health Care Staff Vaccination…
Perspective
Record-high COVID-19 hospitalizations and cases. Unprecedented workforce shortages. Persistent supply chain challenges.  These are only a few of the many…
Blog
To help hospitals and health system leaders stay up-to-date on all of the legal developments related to vaccine mandates, the AHA has developed a blog…
Headline
The U.S. Supreme Court today allowed the Centers for Medicare & Medicaid Services vaccine mandate to go into effect nationwide while blocking the…
Headline
Leaders from the AHA and the American College of Obstetricians and Gynecologists, hospital leaders, clinicians and experts from the Centers for Disease Control…